Literature DB >> 16899196

TACI mutation in common variable immunodeficiency and IgA deficiency.

Rima Rachid1, Emanuela Castigli, Raif S Geha, Francisco A Bonilla.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous primary immunodeficiency disease. Immunoglobulin A deficiency (IGAD) shares some clinical, laboratory, and genetic features with CVID and occurs with relatively greater frequency in first-degree relatives of individuals with CVID. Recently, patients with CVID and IGAD have been found to have mutations of the gene TNFRSF13B encoding the TACI (transmembrane activator and calcium-modulator and cyclophilin-ligand interactor), a member of the tumor necrosis factor-receptor superfamily. In this article, we review the various TACI mutations that have been identified so far. Although six mutations have been reported, no clear genotype-phenotype association has been shown to date. This suggests that the phenotypic expression of TACI mutation is affected by additional genetic and environmental factors. Analysis of a larger sample of patients will be needed to determine if the specific mutations are associated with a particular phenotype or predisposition to the common features of CVID and IGAD: autoimmunity, lymphoproliferation, or malignancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899196     DOI: 10.1007/s11882-996-0004-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  34 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

Authors:  G U von Bülow; R J Bram
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

4.  Clinical and immunologic analyses of 103 patients with common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

5.  Hypogammaglobulinemia and selective immunoglobulin A deficiency. Double consanguinity in family.

Authors:  F Rosner; V Vallejo; F A Khan; Z Wessely; H W Grünwald; C Calas
Journal:  N Y State J Med       Date:  1978-08

6.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

7.  Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency.

Authors:  Jana Kralovicova; Lennart Hammarström; Alessandro Plebani; A David B Webster; Igor Vorechovsky
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 8.  CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1).

Authors:  N Ramesh; T Morio; R Fuleihan; M Worm; A Horner; E Tsitsikov; E Castigli; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1995-09

9.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Abnormal responses of common variable immunodeficiency patients' B cells to Staphylococcus aureus Cowan I and interleukin-2.

Authors:  Y Inoue; N Kondo; F Motoyoshi; R Inoue; T Orii
Journal:  Acta Paediatr       Date:  1993-04       Impact factor: 2.299

View more
  15 in total

1.  Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.

Authors:  V Ballegaard; H Permin; T L Katzenstein; H V Marquart; L Schejbel
Journal:  J Clin Immunol       Date:  2013-05-07       Impact factor: 8.317

2.  B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

Authors:  E Becerra; I De La Torre; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2017-09-25       Impact factor: 4.330

Review 3.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

4.  Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study.

Authors:  Sang-Hwa Urm; Hyun Don Yun; Yilma A Fenta; Kwang Ha Yoo; Roshini S Abraham; John Hagan; Young J Juhn
Journal:  Mayo Clin Proc       Date:  2013-08       Impact factor: 7.616

Review 5.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

Review 6.  Educational paper: primary antibody deficiencies.

Authors:  Gertjan Driessen; Mirjam van der Burg
Journal:  Eur J Pediatr       Date:  2011-05-05       Impact factor: 3.183

7.  Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.

Authors:  Thierry Vilboux; Carla Ciccone; Jan K Blancato; Gerald F Cox; Charu Deshpande; Wendy J Introne; William A Gahl; Ann C M Smith; Marjan Huizing
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

8.  Hypogammaglobulinemia in BLT humanized mice--an animal model of primary antibody deficiency.

Authors:  Francisco Martinez-Torres; Tomonori Nochi; Angela Wahl; J Victor Garcia; Paul W Denton
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

9.  Deficit of Anterior Pituitary Function and Variable Immune Deficiency Syndrome: A Novel Mutation.

Authors:  Pavadee Poowuttikul; Eric McGrath; Deepak Kamat
Journal:  Glob Pediatr Health       Date:  2017-01-27

Review 10.  [Humoral immunodeficiency : awareness for better support].

Authors:  Jalila El Bakkouri; Zahra Aadam; Fatima Ailal; Hanane Salih Alj; Ahmed Aziz Bousfiha
Journal:  Pan Afr Med J       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.